Large firm rating | Citibank: The policy environment is more supportive of pharmaceutical stocks, increasing the allocation weight for Stone Pharmaceutical and Jiangsu Hengrui Pharmaceuticals.

Gelonghui FinanceMay 13 14:25

Yao Ming Kangde (603259): TIDES business is growing rapidly, capacity construction is speeding up

GuosenMay 10 07:37

Yao Ming Kangde (603259) 25th Quarterly Report Review: TIDES's business exceeded expectations and led to strong overall growth

GUOTAI HAITONG SECMay 9 00:00

Yao Ming Kangde (603259): Performance exceeded expectations, ongoing orders continued to grow well

China MerchantsMay 9 00:00

Research Reports Gold Mining | China International Capital Corporation: Maintain WUXI APPTEC's "Outperform Industry" Rating, Order Growth is Strong.

Gelonghui FinanceMay 6 14:41

Yao Ming Kangde (603259) 2025 Quarterly Report Review: Excellent profit margin performance, no change in guidance throughout the year

Yongxing SecuritiesMay 6 00:00

[Brokerage Focus] Zhongtai International raised WUXI APPTEC (02359) to a "Buy" rating, indicating that the impact of USA tariffs is limited in the short term.

Jinwu Financial NewsMay 2 14:15

Yao Ming Kangde (603259): Orders maintain strong growth, TIDES business continues to gain strength

China International Capital CorporationMay 1 11:22

[Brokerage Focus] China Merchants International maintains a Buy rating on WUXI APPTEC (02359) and points out that a good start in Q1 2025 helps the company cope with macro challenges.

Jingwu Financial NewsApr 30 13:55

Yao Ming Kangde (603259): Performance growth exceeds market expectations, TIDES business contributes to core performance flexibility

HuaxiApr 29 21:14

WUXI APPTEC(2359.HK):1Q25 RESULTS BEAT DRIVEN BY STRONG CORE GROWTH

Apr 29 15:17

Nomura: Maintain WUXI APPTEC (02359) "Buy" rating, Target Price 84.59 HKD.

Zhitong FinanceApr 29 14:43

Major banks rating丨UBS Group: Raised WUXI APPTEC's Target Price to HKD 82.5, first-quarter performance exceeded expectations.

Gelonghui FinanceApr 29 11:04

Yao Ming Kangde (603259): TIDES business drives high performance growth in 1Q25

HTSCApr 28 00:00

Yao Ming Kangde (603259): Ongoing orders grew rapidly, 2025Q1 performance improved significantly

Anxin SecuritiesApr 28 00:00

Yao Ming Kangde (603259): Revenue increased quarterly and month-on-month, and the new molecule business grew rapidly

GuosenApr 21 09:27

Morgan Stanley: The trend of order backlog and performance guidance confirm the outlook improvement for WuXi companies, raising the Target Price.

Zhitong FinanceApr 7 14:02

Big bank rating | Morgan Stanley: The outlook for the three companies in the WUXI XDC system has improved, with WUXI XDC still being the preferred choice.

Gelonghui FinanceApr 7 13:27

Research Reports: CICC maintains WUXI APPTEC's "Buy" rating, with strong resilience in operation.

Gelonghui FinanceMar 31 17:05

Yao Ming Kangde (603259): TIDES business with strong resilience is growing rapidly

CITIC SecuritiesMar 31 13:22